Over the past decade, there has been a notable surge in research dedicated to unraveling the intricate role of tight junction proteins in blood-brain barrier (BBB) damage associated with ischemic stroke. This bibliometric analysis explores the expansive landscape of occludin research, a key tight junction protein, during the years 2000-2023, shedding light on the global scientific contributions, collaborations, and emerging trends in this critical area of stroke pathogenesis. China and the United States emerge as significant contributors, underscoring their prominence in advancing our understanding of tight junction proteins.
View Article and Find Full Text PDFStroke continues to be a major global health concern, accounting for the fifth highest death rate and a sizable portion of the world's disability burden. Over 40,000 stroke cases are reported annually in the Republic of Kazakhstan, of which 5,000 people die within the first 10 days and an additional 5,000 within a month after discharge. Even with the establishment of regional stroke centers, a state anti-stroke program, and substantial efforts, rural communities still experience higher rates of stroke-related morbidity and mortality.
View Article and Find Full Text PDFThe Montreal Cognitive Assessment (MoCA) is a brief cognitive evaluation tool that has been developed for screening of patients for Mild Cognitive Impairment (MCI). MCI is a recognized high-risk state for Alzheimer's disease development. The aim of the present study was to create a Kazakh-language adaptation of the original version of the Montreal Cognitive Assessment (version 7.
View Article and Find Full Text PDFAt present, the problem of differential diagnosis and therapy of Parkinson's disease and essential tremor is one of the topical issues of modern clinical neurology. Despite the nosological independence of these diseases, there is evidence of their pathogenetic relationship. The article presents a review of the results of modern scientific research devoted to the study of criteria for diagnosing Parkinson's disease and essential tremor.
View Article and Find Full Text PDFIn predicting outcomes in patients with acute brain injury, current practice focuses special attention on neuron-specific proteins that reliably reflect the severity of the lesion. Further studies of molecular markers and their specificity and sensitivity could contribute to broadening the understanding of pathophysiological, diagnostic, and prognostic methods, which is vital to reducing the mortality and disability associated with these critical conditions. The purpose of this study was to assess the biomarkers of brain lesions and their correlative relations with the integral Glasgow Coma Scale (GCS) and National Institutes of Health Stroke Scale (NIHSS) in predicting severity and treatment outcomes in patients with acute neuropathologies.
View Article and Find Full Text PDF